New

Whole Genome Amplification Market

2021

Whole Genome Amplification Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA and Chip DNA Kit, Others); Application (Drug Discovery and Development, Disease Diagnosis, Agriculture and Veterinary, Research, Forensics, Others); End-User (Pharma and Biotech Companies, Hospitals and Clinics, Contract Research Organizations, Research and Academic Institutes, Others) and Geography

| Report Code: TIPRE00020831 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Market Insights

Whole Genome Amplification Market 2028 By Product Type, Application, End-User and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Single-cell whole genome amplification is the highly favored technique in Biotechnologies labs. Advances in primer technologies and lysing techniques have led to more reliable and accurate whole-cell genome amplification. Single-cell WGA is used to examine the sequence information with the optimized next-generation technologies, only from a single cell.

MARKET DYNAMICS

The Whole Genome Amplification market is driving due to the Surge in the aging population along with increase in the cases of chronic diseases such as arthritis, heart disorders, and cancer. Moreover, the expenditure in research and development of drug will create lucrative opportunity in growth of this market.

MARKET SCOPE

The "Whole Genome Amplification Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with/ a special focus on the global market trend analysis. The report aims to provide an overview of Whole Genome Amplification market with detailed market segmentation by, product type, application and end-user. The whole genome amplification market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in whole genome amplification Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Whole Genome Amplification market is segmented on the basis of product type, application and end-user. Based on product type, the market is segmented as Single Cell WGA Kit, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit, Others. Based on application the market is segmented into Drug Discovery & Development, Disease Diagnosis, Agriculture & Veterinary, Research, Forensics, Others. Based on end-user the market is segmented into Pharma & Biotech Companies, Hospitals & Clinics, Contract Research Organizations, Research & Academic Institutes, Others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Whole Genome Amplification Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Whole Genome Amplification Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Whole Genome Amplification Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the Whole Genome Amplification Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Whole Genome Amplification Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Whole Genome Amplification Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Whole Genome Amplification Market in the global market. Below mentioned is the list of few companies engaged in the Whole Genome Amplification market.

The report also includes the profiles of key players in Whole Genome Amplification market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   GE Healthcare
  •   Sygnis AG
  •   Illumina, Inc.
  •   Merck KGaA
  •   Thermo Fisher Scientific Inc.
  •   Eurofins Scientific
  •   Agilent Technologies, Inc.
  •   Oxford Nanopore Technologies
  •   F. Hoffmann-La Roche Ltd
  •   Bio-Rad Laboratories, Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1.INTRODUCTION
1.1.SCOPE OF THE STUDY
1.2.THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3.MARKET SEGMENTATION
1.3.1Whole Genome Amplification Market - By Product Type
1.3.2Whole Genome Amplification Market - By Application
1.3.3Whole Genome Amplification Market - By End-User
1.3.4Whole Genome Amplification Market - By Region
1.3.4.1By Country

2.KEY TAKEAWAYS

3.RESEARCH METHODOLOGY

4.WHOLE GENOME AMPLIFICATION MARKET LANDSCAPE
4.1.OVERVIEW
4.2.PEST ANALYSIS
4.2.1North America - Pest Analysis
4.2.2Europe - Pest Analysis
4.2.3Asia-Pacific - Pest Analysis
4.2.4Middle East and Africa - Pest Analysis
4.2.5South and Central America - Pest Analysis
4.3.EXPERT OPINIONS

5.WHOLE GENOME AMPLIFICATION MARKET - KEY MARKET DYNAMICS
5.1.KEY MARKET DRIVERS
5.2.KEY MARKET RESTRAINTS
5.3.KEY MARKET OPPORTUNITIES
5.4.FUTURE TRENDS
5.5.IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.WHOLE GENOME AMPLIFICATION MARKET - GLOBAL MARKET ANALYSIS
6.1.WHOLE GENOME AMPLIFICATION - GLOBAL MARKET OVERVIEW
6.2.WHOLE GENOME AMPLIFICATION - GLOBAL MARKET AND FORECAST TO 2028
6.3.MARKET POSITIONING/MARKET SHARE

7.WHOLE GENOME AMPLIFICATION MARKET - REVENUE AND FORECASTS TO 2028 â" PRODUCT TYPE
7.1.OVERVIEW
7.2.PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3.WGA KIT
7.3.1.Overview
7.3.2.WGA Kit Market Forecast and Analysis
7.4.COMPLETE WGA KIT
7.4.1.Overview
7.4.2.Complete WGA Kit Market Forecast and Analysis
7.5.WGA REAMPLIFICATION KIT
7.5.1.Overview
7.5.2.WGA Reamplification Kit Market Forecast and Analysis
7.6.WGA AND CHIP DNA KIT
7.6.1.Overview
7.6.2.WGA and Chip DNA Kit Market Forecast and Analysis
7.7.OTHERS
7.7.1.Overview
7.7.2.Others Market Forecast and Analysis
8.WHOLE GENOME AMPLIFICATION MARKET - REVENUE AND FORECASTS TO 2028 â" APPLICATION
8.1.OVERVIEW
8.2.APPLICATION MARKET FORECASTS AND ANALYSIS
8.3.DRUG DISCOVERY AND DEVELOPMENT
8.3.1.Overview
8.3.2.Drug Discovery and Development Market Forecast and Analysis
8.4.DISEASE DIAGNOSIS
8.4.1.Overview
8.4.2.Disease Diagnosis Market Forecast and Analysis
8.5.AGRICULTURE AND VETERINARY
8.5.1.Overview
8.5.2.Agriculture and Veterinary Market Forecast and Analysis
8.6.RESEARCH
8.6.1.Overview
8.6.2.Research Market Forecast and Analysis
8.7.FORENSICS
8.7.1.Overview
8.7.2.Forensics Market Forecast and Analysis
8.8.OTHERS
8.8.1.Overview
8.8.2.Others Market Forecast and Analysis
9.WHOLE GENOME AMPLIFICATION MARKET - REVENUE AND FORECASTS TO 2028 â" END-USER
9.1.OVERVIEW
9.2.END-USER MARKET FORECASTS AND ANALYSIS
9.3.PHARMA AND BIOTECH COMPANIES
9.3.1.Overview
9.3.2.Pharma and Biotech Companies Market Forecast and Analysis
9.4.HOSPITALS AND CLINICS
9.4.1.Overview
9.4.2.Hospitals and Clinics Market Forecast and Analysis
9.5.CONTRACT RESEARCH ORGANIZATIONS
9.5.1.Overview
9.5.2.Contract Research Organizations Market Forecast and Analysis
9.6.RESEARCH AND ACADEMIC INSTITUTES
9.6.1.Overview
9.6.2.Research and Academic Institutes Market Forecast and Analysis
9.7.OTHERS
9.7.1.Overview
9.7.2.Others Market Forecast and Analysis

10.WHOLE GENOME AMPLIFICATION MARKET REVENUE AND FORECASTS TO 2028 â" GEOGRAPHICAL ANALYSIS
10.1.NORTH AMERICA
10.1.1North America Whole Genome Amplification Market Overview
10.1.2North America Whole Genome Amplification Market Forecasts and Analysis
10.1.3North America Whole Genome Amplification Market Forecasts and Analysis - By Product Type
10.1.4North America Whole Genome Amplification Market Forecasts and Analysis - By Application
10.1.5North America Whole Genome Amplification Market Forecasts and Analysis - By End-User
10.1.6North America Whole Genome Amplification Market Forecasts and Analysis - By Countries
10.1.6.1United States Whole Genome Amplification Market
10.1.6.1.1United States Whole Genome Amplification Market by Product Type
10.1.6.1.2United States Whole Genome Amplification Market by Application
10.1.6.1.3United States Whole Genome Amplification Market by End-User
10.1.6.2Canada Whole Genome Amplification Market
10.1.6.2.1Canada Whole Genome Amplification Market by Product Type
10.1.6.2.2Canada Whole Genome Amplification Market by Application
10.1.6.2.3Canada Whole Genome Amplification Market by End-User
10.1.6.3Mexico Whole Genome Amplification Market
10.1.6.3.1Mexico Whole Genome Amplification Market by Product Type
10.1.6.3.2Mexico Whole Genome Amplification Market by Application
10.1.6.3.3Mexico Whole Genome Amplification Market by End-User
10.2.EUROPE
10.2.1Europe Whole Genome Amplification Market Overview
10.2.2Europe Whole Genome Amplification Market Forecasts and Analysis
10.2.3Europe Whole Genome Amplification Market Forecasts and Analysis - By Product Type
10.2.4Europe Whole Genome Amplification Market Forecasts and Analysis - By Application
10.2.5Europe Whole Genome Amplification Market Forecasts and Analysis - By End-User
10.2.6Europe Whole Genome Amplification Market Forecasts and Analysis - By Countries
10.2.6.1Germany Whole Genome Amplification Market
10.2.6.1.1Germany Whole Genome Amplification Market by Product Type
10.2.6.1.2Germany Whole Genome Amplification Market by Application
10.2.6.1.3Germany Whole Genome Amplification Market by End-User
10.2.6.2France Whole Genome Amplification Market
10.2.6.2.1France Whole Genome Amplification Market by Product Type
10.2.6.2.2France Whole Genome Amplification Market by Application
10.2.6.2.3France Whole Genome Amplification Market by End-User
10.2.6.3Italy Whole Genome Amplification Market
10.2.6.3.1Italy Whole Genome Amplification Market by Product Type
10.2.6.3.2Italy Whole Genome Amplification Market by Application
10.2.6.3.3Italy Whole Genome Amplification Market by End-User
10.2.6.4Spain Whole Genome Amplification Market
10.2.6.4.1Spain Whole Genome Amplification Market by Product Type
10.2.6.4.2Spain Whole Genome Amplification Market by Application
10.2.6.4.3Spain Whole Genome Amplification Market by End-User
10.2.6.5United Kingdom Whole Genome Amplification Market
10.2.6.5.1United Kingdom Whole Genome Amplification Market by Product Type
10.2.6.5.2United Kingdom Whole Genome Amplification Market by Application
10.2.6.5.3United Kingdom Whole Genome Amplification Market by End-User
10.2.6.6Rest of Europe Whole Genome Amplification Market
10.2.6.6.1Rest of Europe Whole Genome Amplification Market by Product Type
10.2.6.6.2Rest of Europe Whole Genome Amplification Market by Application
10.2.6.6.3Rest of Europe Whole Genome Amplification Market by End-User
10.3.ASIA-PACIFIC
10.3.1Asia-Pacific Whole Genome Amplification Market Overview
10.3.2Asia-Pacific Whole Genome Amplification Market Forecasts and Analysis
10.3.3Asia-Pacific Whole Genome Amplification Market Forecasts and Analysis - By Product Type
10.3.4Asia-Pacific Whole Genome Amplification Market Forecasts and Analysis - By Application
10.3.5Asia-Pacific Whole Genome Amplification Market Forecasts and Analysis - By End-User
10.3.6Asia-Pacific Whole Genome Amplification Market Forecasts and Analysis - By Countries
10.3.6.1Australia Whole Genome Amplification Market
10.3.6.1.1Australia Whole Genome Amplification Market by Product Type
10.3.6.1.2Australia Whole Genome Amplification Market by Application
10.3.6.1.3Australia Whole Genome Amplification Market by End-User
10.3.6.2China Whole Genome Amplification Market
10.3.6.2.1China Whole Genome Amplification Market by Product Type
10.3.6.2.2China Whole Genome Amplification Market by Application
10.3.6.2.3China Whole Genome Amplification Market by End-User
10.3.6.3India Whole Genome Amplification Market
10.3.6.3.1India Whole Genome Amplification Market by Product Type
10.3.6.3.2India Whole Genome Amplification Market by Application
10.3.6.3.3India Whole Genome Amplification Market by End-User
10.3.6.4Japan Whole Genome Amplification Market
10.3.6.4.1Japan Whole Genome Amplification Market by Product Type
10.3.6.4.2Japan Whole Genome Amplification Market by Application
10.3.6.4.3Japan Whole Genome Amplification Market by End-User
10.3.6.5South Korea Whole Genome Amplification Market
10.3.6.5.1South Korea Whole Genome Amplification Market by Product Type
10.3.6.5.2South Korea Whole Genome Amplification Market by Application
10.3.6.5.3South Korea Whole Genome Amplification Market by End-User
10.3.6.6Rest of Asia-Pacific Whole Genome Amplification Market
10.3.6.6.1Rest of Asia-Pacific Whole Genome Amplification Market by Product Type
10.3.6.6.2Rest of Asia-Pacific Whole Genome Amplification Market by Application
10.3.6.6.3Rest of Asia-Pacific Whole Genome Amplification Market by End-User
10.4.MIDDLE EAST AND AFRICA
10.4.1Middle East and Africa Whole Genome Amplification Market Overview
10.4.2Middle East and Africa Whole Genome Amplification Market Forecasts and Analysis
10.4.3Middle East and Africa Whole Genome Amplification Market Forecasts and Analysis - By Product Type
10.4.4Middle East and Africa Whole Genome Amplification Market Forecasts and Analysis - By Application
10.4.5Middle East and Africa Whole Genome Amplification Market Forecasts and Analysis - By End-User
10.4.6Middle East and Africa Whole Genome Amplification Market Forecasts and Analysis - By Countries
10.4.6.1South Africa Whole Genome Amplification Market
10.4.6.1.1South Africa Whole Genome Amplification Market by Product Type
10.4.6.1.2South Africa Whole Genome Amplification Market by Application
10.4.6.1.3South Africa Whole Genome Amplification Market by End-User
10.4.6.2Saudi Arabia Whole Genome Amplification Market
10.4.6.2.1Saudi Arabia Whole Genome Amplification Market by Product Type
10.4.6.2.2Saudi Arabia Whole Genome Amplification Market by Application
10.4.6.2.3Saudi Arabia Whole Genome Amplification Market by End-User
10.4.6.3U.A.E Whole Genome Amplification Market
10.4.6.3.1U.A.E Whole Genome Amplification Market by Product Type
10.4.6.3.2U.A.E Whole Genome Amplification Market by Application
10.4.6.3.3U.A.E Whole Genome Amplification Market by End-User
10.4.6.4Rest of Middle East and Africa Whole Genome Amplification Market
10.4.6.4.1Rest of Middle East and Africa Whole Genome Amplification Market by Product Type
10.4.6.4.2Rest of Middle East and Africa Whole Genome Amplification Market by Application
10.4.6.4.3Rest of Middle East and Africa Whole Genome Amplification Market by End-User
10.5.SOUTH AND CENTRAL AMERICA
10.5.1South and Central America Whole Genome Amplification Market Overview
10.5.2South and Central America Whole Genome Amplification Market Forecasts and Analysis
10.5.3South and Central America Whole Genome Amplification Market Forecasts and Analysis - By Product Type
10.5.4South and Central America Whole Genome Amplification Market Forecasts and Analysis - By Application
10.5.5South and Central America Whole Genome Amplification Market Forecasts and Analysis - By End-User
10.5.6South and Central America Whole Genome Amplification Market Forecasts and Analysis - By Countries
10.5.6.1Brazil Whole Genome Amplification Market
10.5.6.1.1Brazil Whole Genome Amplification Market by Product Type
10.5.6.1.2Brazil Whole Genome Amplification Market by Application
10.5.6.1.3Brazil Whole Genome Amplification Market by End-User
10.5.6.2Argentina Whole Genome Amplification Market
10.5.6.2.1Argentina Whole Genome Amplification Market by Product Type
10.5.6.2.2Argentina Whole Genome Amplification Market by Application
10.5.6.2.3Argentina Whole Genome Amplification Market by End-User
10.5.6.3Rest of South and Central America Whole Genome Amplification Market
10.5.6.3.1Rest of South and Central America Whole Genome Amplification Market by Product Type
10.5.6.3.2Rest of South and Central America Whole Genome Amplification Market by Application
10.5.6.3.3Rest of South and Central America Whole Genome Amplification Market by End-User

11.INDUSTRY LANDSCAPE
11.1.MERGERS AND ACQUISITIONS
11.2.AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3.NEW PRODUCT LAUNCHES
11.4.EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12.WHOLE GENOME AMPLIFICATION MARKET, KEY COMPANY PROFILES
12.1.GE HEALTHCARE
12.1.1.Key Facts
12.1.2.Business Description
12.1.3.Products and Services
12.1.4.Financial Overview
12.1.5.SWOT Analysis
12.1.6.Key Developments
12.2.SYGNIS AG
12.2.1.Key Facts
12.2.2.Business Description
12.2.3.Products and Services
12.2.4.Financial Overview
12.2.5.SWOT Analysis
12.2.6.Key Developments
12.3.ILLUMINA, INC.
12.3.1.Key Facts
12.3.2.Business Description
12.3.3.Products and Services
12.3.4.Financial Overview
12.3.5.SWOT Analysis
12.3.6.Key Developments
12.4.MERCK KGAA
12.4.1.Key Facts
12.4.2.Business Description
12.4.3.Products and Services
12.4.4.Financial Overview
12.4.5.SWOT Analysis
12.4.6.Key Developments
12.5.THERMO FISHER SCIENTIFIC INC.
12.5.1.Key Facts
12.5.2.Business Description
12.5.3.Products and Services
12.5.4.Financial Overview
12.5.5.SWOT Analysis
12.5.6.Key Developments
12.6.EUROFINS SCIENTIFIC
12.6.1.Key Facts
12.6.2.Business Description
12.6.3.Products and Services
12.6.4.Financial Overview
12.6.5.SWOT Analysis
12.6.6.Key Developments
12.7.AGILENT TECHNOLOGIES, INC.
12.7.1.Key Facts
12.7.2.Business Description
12.7.3.Products and Services
12.7.4.Financial Overview
12.7.5.SWOT Analysis
12.7.6.Key Developments
12.8.OXFORD NANOPORE TECHNOLOGIES
12.8.1.Key Facts
12.8.2.Business Description
12.8.3.Products and Services
12.8.4.Financial Overview
12.8.5.SWOT Analysis
12.8.6.Key Developments
12.9.F. HOFFMANN-LA ROCHE LTD
12.9.1.Key Facts
12.9.2.Business Description
12.9.3.Products and Services
12.9.4.Financial Overview
12.9.5.SWOT Analysis
12.9.6.Key Developments
12.10.BIO-RAD LABORATORIES, INC.
12.10.1.Key Facts
12.10.2.Business Description
12.10.3.Products and Services
12.10.4.Financial Overview
12.10.5.SWOT Analysis
12.10.6.Key Developments

13.APPENDIX
13.1.ABOUT THE INSIGHT PARTNERS
13.2.GLOSSARY OF TERMS
The List of Companies

1. GE Healthcare
2. Sygnis AG
3. Illumina, Inc.
4. Merck KGaA
5. Thermo Fisher Scientific Inc.
6. Eurofins Scientific
7. Agilent Technologies, Inc.
8. Oxford Nanopore Technologies
9. F. Hoffmann-La Roche Ltd
10. Bio-Rad Laboratories, Inc
TIPRE00020831
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.